Background illustration for clinical trials search

Paid Clinical Trials Chicago

Discover 2,374 paid clinical trials in Chicago, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

for
Intracranial Meningioma, Recurrent Meningioma,
Location: Chicago IL, Oak Park IL, Oak Lawn IL, Park Ridge IL,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT02523014

Phase2, Recruiting

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

for
Chronic Kidney Disease and Hypertension
Location: Maywood IL, Saint Joseph MI, Rockford IL, Champaign IL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06742723

Phase3, Recruiting

Enhancing Diabetes Care: Exposome &Amp; Sensors

for
Type 2 Diabetes
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: All

Age: 18 - 65

Code: NCT06989008

Recruiting

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

for
Prostate Cancer
Location: Chicago IL, Chicago Ridge IL, Greenwood IN, Columbus OH,
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT06952803

Phase3, Recruiting

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

for
Acute Treatment of Migraine
Location: Chicago IL, Naperville IL, Madison WI, Grand Rapids MI,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04743141

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis

for
Severe Hypertriglyceridemia
Location: Springfield IL, Indianapolis IN, Ann Arbor MI,
Sponsor: Arrowhead Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06880770

Phase3, Recruiting

Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation

for
Prostate Cancer
Location: Chicago IL
Sponsor: University of Chicago

Sex: Male

Age: 18+

Code: NCT05790213

Phase2, Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Chicago IL, Elmhurst IL, Madison WI, Fort Wayne IN,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase3, Recruiting

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: Chicago IL, Iowa City IA, Franklin TN, Toronto,
Sponsor: AstraZeneca

Sex: All

Age: 12+

Code: NCT07109219

Phase1, Phase2, Recruiting

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

for
Type 2 Diabetes, Cortisol Excess
Location: Chicago IL, Troy MI, Cincinnati OH, Edgewood KY,
Sponsor: Sparrow Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07296484

Phase2, Recruiting

Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis

for
Bacterial Conjunctivitis
Location: Orland Park IL, Charlottesville VA, Little Rock AR,
Sponsor: Baxis Pharmaceuticals, Inc.

Sex: All

Age: 0+

Code: NCT06911424

Phase3, Recruiting

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

for
Schizophrenia
Location: Chicago IL, Little Rock AR, Bryant AR, Gaithersburg MD,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT06963034

Phase3, Recruiting

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

for
Pancreatic Acinar Cell Carcinoma,
Location: Chicago IL, Elmhurst IL, Orland Park IL, Munster IN,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04858334

Phase2, Recruiting

A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD

for
Sickle Cell Disease
Location: Chicago IL, Kansas City MO, Travelers Rest SC, Greer SC,
Sponsor: Pfizer

Sex: All

Age: 12+

Code: NCT05431088

Phase2, Phase3, Recruiting

Real World Effectiveness of the Cordella Pulmonary Artery Sensor System in Patients With Chronic Heart Heart Failure

for
Heart Failure NYHA Class III, Heart Failure
Location: Naperville IL
Sponsor: Endotronix, Inc.

Sex: All

Age: 18+

Code: NCT06783335

Recruiting

Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

for
Kidney Cancer
Location: Maywood IL, Indianapolis IN, Detroit MI, Nashville TN,
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT00301990

Phase2, Recruiting

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

for
Intracerebral Hemorrhage, Atrial Fibrillation
Location: Chicago IL, Maywood IL, Evanston IL,
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT03907046

Phase3, Recruiting

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

for
Fibromyalgia
Location: Chicago IL, Tinley Park IL, Huber Heights OH,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07398417

Phase3, Recruiting

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

for
Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms,
Location: Chicago IL, Cincinnati OH, Memphis TN, Norcross GA,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT07484217

Phase3, Recruiting

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

for
Metastatic Small Intestinal Adenocarcinoma,
Location: Chicago IL, Orland Park IL, New Lenox IL, Aurora IL,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04205968

Phase2, Recruiting

Chicago is a vital city for clinical research, offering a robust healthcare network and renowned medical research institutions. Major facilities such as The University of Chicago Medicine, Northwestern Medicine, and Rush University Medical Center are at the forefront of pioneering research across various fields, including cancer, cardiovascular health, and neurological disorders.

Why choose Chicago for clinical trials?

The city of Chicago offers many advantages for individuals considering participation in clinical trials. With a diverse and vibrant population, researchers benefit from the variety of participants, improving the reliability and applicability of research findings across different demographics.

By opting to participate in a clinical trial in Chicago, individuals not only gain access to cutting-edge therapies and treatments but also contribute to vital medical research. This collaborative effort is supported by a robust clinical research infrastructure, ensuring participants receive high-quality care and attention while playing a crucial role in shaping the future of healthcare.

Common conditions studied in Chicago

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Chicago